Adents, Siemens Team on Serialization Solution
PTSM: Pharmaceutical Technology Sourcing and Management
Siemens and ADENTS develop joint solution for drug serialization challenges.
Technology equipment provider Siemens has teamed up with Adents, a provider of serialisation and track-and-trace software solutions, to develop a combined hardware and software solution providing drug manufacturers with item-level serialization capabilities, an Adents press statement reports.
The joint offering comprises Siemens’ industrial PCs, software controllers, I/Os and camera barcode readers and Adents’ Pharma Suite software, which manages serialization parameters from a centralized server at site level (Level 3). The companies repor that the solution can easily be integrated into existing infrastructure and equipment, and can handle existing and future regulatory requirements. Unit-level track and trace rules can be modified continuously for a variety of production types.
The Siemens-Adents solution requires fewer qualification tests needed; offers exceptional performance on high speed packaging lines; and provides solution and implementation management that meet the industry quality standards, such as the GAMP5 guidelines.
Source: Adents
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
